Heidemarie Becker

Summary

Country: Germany

Publications

  1. ncbi request reprint [Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options]
    H Becker
    Med Klinik und Poliklinik B, Universitatsklinikum Munster
    Z Gastroenterol 44:497-502. 2006
  2. ncbi request reprint Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides
    Heidemarie Becker
    Department of Medicine B, University of Muenster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    Clin Rheumatol 25:368-72. 2006
  3. doi request reprint Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis
    Heidemarie Becker
    Department of Medicine B, University of Muenster, Albert Schweitzer Str 33, 48129, Muenster, Germany
    Clin Rheumatol 27:1307-11. 2008
  4. doi request reprint [Leg ulcer in mixed connective tissue disease. Resolution during sitaxsentan therapy]
    H Becker
    Medizinische Klinik und Poliklinik D, Universitatsklinikum Munster, Albert Schweitzer Str 33, 48149 Munster
    Z Rheumatol 68:154-6. 2009
  5. ncbi request reprint Emerging treatment strategies and potential therapeutic targets in primary Sjögren's syndrome
    Heidemarie Becker
    Department of Medicine D, University of Muenster, Muenster, Germany
    Inflamm Allergy Drug Targets 9:10-9. 2010
  6. pmc Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome
    Peter Willeke
    Department of Medicine B, Muenster University Hospital, Albert Schweitzer Strasse 33, 48129 Muenster, Germany
    Arthritis Res Ther 9:R43. 2007
  7. doi request reprint Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon
    Peter Willeke
    Department of Medicine B, Muenster University Hospital, Muenster, Germany
    Semin Arthritis Rheum 39:197-202. 2009
  8. pmc Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
    Peter Willeke
    Department of Medicine B, Muenster University Hospital, Albert Schweitzer Street 33, D 48129 Muenster, Germany
    Arthritis Res Ther 9:R115. 2007
  9. ncbi request reprint Clinical utility of the anti-CCP assay: experiences with 700 patients
    Ulrich Sauerland
    Department of Medicine B, Munster University Hospital, Albert Schweitzer Strasse 33, D 48129 Munster, Germany
    Ann N Y Acad Sci 1050:314-8. 2005

Collaborators

Detail Information

Publications9

  1. ncbi request reprint [Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options]
    H Becker
    Med Klinik und Poliklinik B, Universitatsklinikum Munster
    Z Gastroenterol 44:497-502. 2006
    ..For patients who fail to respond to TNF blockade, the emergence of other targets of the inflammatory cascade may provide more treatment choices in the future...
  2. ncbi request reprint Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides
    Heidemarie Becker
    Department of Medicine B, University of Muenster, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    Clin Rheumatol 25:368-72. 2006
    ..The results suggest that MIF contributes to the inflammatory process and correlates with disease activity in antineutrophil cytoplasmic antibody-associated vasculitides...
  3. doi request reprint Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis
    Heidemarie Becker
    Department of Medicine B, University of Muenster, Albert Schweitzer Str 33, 48129, Muenster, Germany
    Clin Rheumatol 27:1307-11. 2008
    ..MIF levels were not significantly different in patients with and without macrovascular disease of the peripheral arteries. The results suggest that MIF might contribute to inflammation and vasculopathy in SSc...
  4. doi request reprint [Leg ulcer in mixed connective tissue disease. Resolution during sitaxsentan therapy]
    H Becker
    Medizinische Klinik und Poliklinik D, Universitatsklinikum Munster, Albert Schweitzer Str 33, 48149 Munster
    Z Rheumatol 68:154-6. 2009
    ..In addition, severity of RP ameliorated markedly. Further evaluation of sitaxsentan in patients with connective tissue diseases suffering from ischemic skin ulcers is required...
  5. ncbi request reprint Emerging treatment strategies and potential therapeutic targets in primary Sjögren's syndrome
    Heidemarie Becker
    Department of Medicine D, University of Muenster, Muenster, Germany
    Inflamm Allergy Drug Targets 9:10-9. 2010
    ..Since efficacy of many agents depends on the presence of residual functional glandular tissue, future studies should focus on patients with recent onset of pSS...
  6. pmc Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome
    Peter Willeke
    Department of Medicine B, Muenster University Hospital, Albert Schweitzer Strasse 33, 48129 Muenster, Germany
    Arthritis Res Ther 9:R43. 2007
    ..MIF may contribute to B-cell hyperactivity indicated by hypergammaglobulinemia. The inverse relationship of IL-10 and MIF suggests that IL-10 works as an antagonist of MIF in pSS...
  7. doi request reprint Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon
    Peter Willeke
    Department of Medicine B, Muenster University Hospital, Muenster, Germany
    Semin Arthritis Rheum 39:197-202. 2009
    ..Since increased interferon-gamma (INF-gamma) has been associated with RP, we also compared the INF-gamma production in pSS patients with or without RP...
  8. pmc Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
    Peter Willeke
    Department of Medicine B, Muenster University Hospital, Albert Schweitzer Street 33, D 48129 Muenster, Germany
    Arthritis Res Ther 9:R115. 2007
    ..Further investigations about the efficacy and safety of MPS in pSS have to be performed in larger numbers of patients...
  9. ncbi request reprint Clinical utility of the anti-CCP assay: experiences with 700 patients
    Ulrich Sauerland
    Department of Medicine B, Munster University Hospital, Albert Schweitzer Strasse 33, D 48129 Munster, Germany
    Ann N Y Acad Sci 1050:314-8. 2005
    ..Anti-CCP also helps to diagnose other inflammatory and noninflammatory diseases (especially connective tissue diseases) by reducing the rate of false-positive results in comparison with RF...